<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-34426</identifier>
<setSpec>1130-6343</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">New drugs in Sapin - when are they to be considered cost-effective alternatives and profitable investments for the National Health System?</dc:title>
<dc:creator>Soto Álvarez, J</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Arán Ediciones, S.A.</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Farm Hosp;28(4): 296-304, jul. 2004.</dc:source>
<dc:identifier>ibc-34426</dc:identifier>
<dc:title xml:lang="es">Nuevos medicamentos en España: ¿cuándo deberían ser considerados alternativas coste-efectivas e inversiones rentables para el Sistema Nacional de Salud?</dc:title>
<dc:subject>^d30313</dc:subject>
<dc:subject>^d13411</dc:subject>
<dc:subject>^d7610</dc:subject>
<dc:subject>^d23106</dc:subject>
<dc:subject>^d24613</dc:subject>
<dc:subject>^d30152</dc:subject>
<dc:subject>^d33652</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9508</dc:subject>
<dc:type>article</dc:type>
<dc:date>200407</dc:date>
</metadata>
</record>
</ibecs-document>
